Trinity Biotech (TRIB) Operating Margin Growth (5y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -7,938.00 |
| Sep 30, 2024 | -2,230.00 |
| Jun 30, 2024 | -3,093.00 |
| Mar 31, 2024 | -2,667.00 |
| Dec 31, 2023 | -3,596.00 |
| Sep 30, 2023 | -3,587.00 |
| Jun 30, 2023 | -11,377.00 |
| Mar 31, 2023 | -3,402.00 |
| Dec 31, 2022 | -5,517.00 |
| Sep 30, 2022 | -5,774.00 |
| Jun 30, 2022 | -1,920.00 |
| Mar 31, 2022 | -1,332.00 |
| Dec 31, 2021 | 38.00 |
| Sep 30, 2021 | 218.00 |
| Jun 30, 2021 | -812.00 |
| Mar 31, 2021 | 427.00 |
| Dec 31, 2020 | 1,511.00 |
| Sep 30, 2020 | 1,685.00 |
| Jun 30, 2020 | -928.00 |
| Mar 31, 2020 | -918.00 |
| Dec 31, 2019 | -933.00 |
| Sep 30, 2019 | -1,167.00 |
| Jun 30, 2019 | -1,231.00 |
| Mar 31, 2019 | -1,201.00 |
| Dec 31, 2018 | -1,119.00 |
| Sep 30, 2018 | -1,464.00 |
| Jun 30, 2018 | -1,030.00 |
| Mar 31, 2018 | -1,155.00 |
| Dec 31, 2017 | -1,778.00 |
| Sep 30, 2017 | -1,489.00 |
| Jun 30, 2017 | -1,345.00 |
| Mar 31, 2017 | -1,508.00 |
| Dec 31, 2016 | -1,797.00 |
| Sep 30, 2016 | -1,028.00 |
| Jun 30, 2016 | -1,102.00 |
| Mar 31, 2016 | -1,207.00 |
| Dec 31, 2015 | -603.00 |
| Sep 30, 2015 | -589.00 |
| Jun 30, 2015 | -310.00 |
| Mar 31, 2015 | 450.00 |
| Dec 31, 2014 | 479.00 |
| Sep 30, 2014 | 533.00 |
| Jun 30, 2014 | 577.00 |
| Mar 31, 2014 | 822.00 |